With the “BioImpulse” project, Michelin aims to produce a new adhesive resin that does not contain substances of very high concern (SVHC). The development of a relevant biobased molecule will open up new avenues for the use of biotechnology in the materials field.
A total budget of $30.9 million (€28.1 million) will be available for the project implementation over the next six years. “BioImpulse” is a venture between public institutions and private sector players coordinated by the Michelin ResiCare business unit. The project was presented for the first time in early October 2019, in Brussels, at the European Forum for Industrial Biotechnology and Bioeconomy (EFIB).
Similarly to biotechnology, CBD and Hemp sector are feeling the growth and is bringing profit on the market. The cannabis industry is predicted to be worth more than $14.67 billion by 2026.
One potentially useful investing tool is Hemp.IM app and its companion hemp news website. Hemp.IM provides the latest news about the CBD and Hemp sector. This important market is beginning to emerge in Poland and the rest of the world and could represent a unique investment opportunity, just like the biotech sector.
Bonding resins are used for high-strength bonded joints, for example in boats, aircraft, machine and vehicle construction. Conventional industrial adhesives usually contain components that are classified as Substances of Very High Concern (SVHC).
Michelin keep sustainable mobility in focus
Michelin, within the framework of the project, will produce a relevant bio-based molecule, which will serve as the starting point for the production of an adhesive resin with sufficient adhesive power. Thus, sustainable mobility is to be achieved right at the beginning of the value chain, i.e. with regard to the materials used.
Taking into account health, economic and environmental aspects, the focus is on environmental design, in particular in the production by fermentation and the use of second-generation biomass, i.e. agricultural and forestry waste that does not compete with food production. The construction of the first industrial production unit is scheduled for 2026.
Cooperation partners are the French Institutes of Technology (FCBA), Agronomy Research (INRA) and Applied Sciences (INSA) and Lesaffre. The project is also supported by the French program for the environment and energy, ADEME.
“With this research project in collaboration with our partners, Michelin is underlining its commitment to the environment, beyond tire manufacturing. We are making available our know-how in the field of sustainable materials to the entire industry,” explains Florent Menegaux, CEO of the Michelin Group.
First published in SpringerProfessional, a third-party contributor translated and adapted the article from the original. In case of discrepancy, the original will prevail.
Although we made reasonable efforts to provide accurate translations, some parts may be incorrect. Born2Invest assumes no responsibility for errors, omissions or ambiguities in the translations provided on this website. Any person or entity relying on translated content does so at their own risk. Born2Invest is not responsible for losses caused by such reliance on the accuracy or reliability of translated information. If you wish to report an error or inaccuracy in the translation, we encourage you to contact us.
DISCLAIMER: This article was written by a third party contributor and does not reflect the opinion of Born2Invest, its management, staff or its associates. Please review our disclaimer for more information.
This article may include forward-looking statements. These forward-looking statements generally are identified by the words “believe,” “project,” “estimate,” “become,” “plan,” “will,” and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties, including those discussed in the following cautionary statements and elsewhere in this article and on this site. Although the Company may believe that its expectations are based on reasonable assumptions, the actual results that the Company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the Company only as of the date hereof. Additionally, please make sure to read these important disclosures.
Another biotech gem from Switzerland secures growth capital
A biotech spin-off from the Universities of Zurich and Basel has received new funds from a financing round with renowned...
Industrial espionage costs German companies $229.4 billion
According to the Federation of German Industries (BDI), data theft, industrial espionage and sabotage have cost German companies $229.1 billion...
French Real Estate Crowdfunding grew by 80% in 2019
Real estate crowdfunding is a new way for investors to raise money for their affairs. Crowdfunding for real estate brings...
Growing Capacity: Why Smart Expansion Is Key To Success Among Cannabis Growers
Soaring demand is driving the cannabis market to new highs, as thousands of under served clients can finally obtain their...
Investors react to the Sanofi-Regeneron collaboration
Regeneron Pharmaceuticals Inc shares rebounded as investors found out about collaboration partner Sanofi SA’s liquidation of its Regeneron stake. The...
- Crypto6 days ago
Swiss licensed crypto bank is expanding into 9 new markets
- Biotech7 days ago
Geman Biotech Stocks: Mologen (MGNK) goes insolvent while MorphoSys (MOR) strengthens its position
- Business4 days ago
Where Social Media is Headed in 2020
- Cannabis7 days ago
Brazilian health authority approves registration of cannabis medicines